Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 9/2015

01-09-2015 | Retraction Note

Retraction Note to: Prognostic value of CD133 expression in cancer patients treated with chemoradiotherapy: a meta-analysis

Authors: Jin-Hai Zhai, Wen-Chao Gu, Xiao-Lin Xu, Jiang Wu, Xue-Jun Hu, Ke-Zhu Hou

Published in: Tumor Biology | Issue 9/2015

Login to get access

Excerpt

Retraction to: Tumor Biol. (2015) 36:701–709 …
Metadata
Title
Retraction Note to: Prognostic value of CD133 expression in cancer patients treated with chemoradiotherapy: a meta-analysis
Authors
Jin-Hai Zhai
Wen-Chao Gu
Xiao-Lin Xu
Jiang Wu
Xue-Jun Hu
Ke-Zhu Hou
Publication date
01-09-2015
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 9/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-3783-6

Other articles of this Issue 9/2015

Tumor Biology 9/2015 Go to the issue

Retraction Note

Retraction Note to: Comparison of hepatocellular carcinoma (HCC), cholangiocarcinoma (CC), and combined HCC-CC (CHC) with each other based on microarray dataset

Research Article

Long non-coding RNA BANCR regulates growth and metastasis and is associated with poor prognosis in retinoblastoma

Review

Malignant tumors of the uterine corpus: molecular background of their origin

Review

MicroRNA-224: as a potential target for miR-based therapy of cancer

Research Article

C-reactive protein inhibits expression of N-cadherin and ZEB-1 in murine colon adenocarcinoma

Research Article

Interaction with CCNH/CDK7 facilitates CtBP2 promoting esophageal squamous cell carcinoma (ESCC) metastasis via upregulating epithelial-mesenchymal transition (EMT) progression
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits